好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Safe to Swallow: Predictors of Swallowing Outcomes after Deep Brain Stimulation for Dystonia
Movement Disorders
S11 - Movement Disorders: Technological Advances in Diagnostics and Therapeutics (4:42 PM-4:54 PM)
007
To define swallowing outcomes after deep brain stimulation (DBS) for dystonia and determine clinical and stimulation factors associated with swallowing safety and efficiency.

DBS provides long-lasting motor benefit in dystonia, yet its effects on swallowing, a vital function for airway protection remain underexplored. Bulbar outcomes are inconsistently reported and often lack objective quantification. Identifying clinical or stimulation-related predictors of swallowing change could refine patient selection toward safer, individualized DBS programming.

 

We retrospectively reviewed 75 dystonia patients who underwent DBS at the University of Florida (2003–2024; GPi = 56, VIM = 12, STN = 4, STN + GPi = 3). Motor outcomes were assessed with the Unified Dystonia Rating Scale, Toronto Western Spasmodic Torticollis Rating Scale, and Burke–Fahn–Marsden Dystonia Rating Scale. Swallowing safety and efficiency were evaluated with the Penetration–Aspiration Scale (PAS) and Dynamic Imaging Grade of Swallowing Toxicity (DIGEST). Pre- and postoperative scores were compared using Wilcoxon signed-rank tests (FDR-corrected). Multivariable regression identified predictors of PAS change, adjusting for baseline PAS, age, disease duration, etiology, phenotype, motor severity, follow-up, and stimulation energy.

DBS improved motor scores across all scales (p < 0.01). Subscores related to orobulbar control, including jaw/tongue and speech-swallowing domains also improved, suggesting concurrent benefit in axial function. Median PAS remained stable, indicating preserved swallowing safety. The regression model for PAS change was significant (F-test p = 0.046; adjusted R² = 0.46). Higher baseline PAS scores predicted greater postoperative improvement (p = 0.075, trend level), whereas no demographic or stimulation parameters correlated with decline. DIGEST models were non-significant.

 

DBS preserved swallowing safety and efficiency and may benefit patients with more  severe swallowing impairment. These findings suggest that DBS modulates pallido–brainstem networks, supporting bulbar coordination without compromising airway protection. Baseline PAS may serve as a marker of postoperative trajectory, supporting a more personalized approach to DBS in dystonia.

Authors/Disclosures
Nur Walker-Pizarro, MD
PRESENTER
Dr. Walker-Pizarro has nothing to disclose.
Hikaru Kamo, MD, PhD Dr. Kamo has received research support from Japan Society for the Promotion of Science.
Karen W. Hegland, Jr., PhD The institution of Prof. Hegland has received research support from APDA. The institution of Prof. Hegland has received research support from NIH. The institution of Prof. Hegland has received research support from NIH. Prof. Hegland has received personal compensation in the range of $5,000-$9,999 for serving as a Expert trainer with Brooks Rehabilitation.
Michael S. Okun, MD, FAAN (University of Florida) Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Adolfo Ramirez Zamora, MD (University of Louisville) Dr. Ramirez Zamora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel therapeutics. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPacs. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota Inc. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Dr. Ramirez Zamora has received research support from Parkinsons Foundation.